Abstract:Background: Pulmonary microvascular endothelial cells (PMVECs) were not complex, and the endothelial barrier was destroyed in the pathogenesis progress of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Previous studies have demonstrated that hepatocyte growth factor (HGF), which was secreted by bone marrow mesenchymal stem cells, could decrease endothelial apoptosis. We investigated whether mTOR/STAT3 signaling acted in HGF protective effects against oxidative stress and mitochondria-dependent apoptosis in lipopolysaccharide (LPS)-induced endothelial barrier dysfunction and ALI mice. Methods: In our current study, we introduced LPS-induced PMEVCs with HGF treatment. To investigate the effects of mammalian target of rapamycin (mTOR)/signal transducer and activator of transcription 3 (STAT3) pathway in endothelial oxidative stress and mitochondria-dependent apoptosis, mTOR inhibitor rapamycin and STAT3 inhibitor S3I-201 were, respectively, used to inhibit mTOR/STAT3 signaling. Moreover, lentivirus vector-mediated mTORC1 (Raptor) and mTORC2 (Rictor) gene knockdown modifications were introduced to evaluate mTORC1 and mTORC1 pathways. Calcium measurement, reactive oxygen species (ROS) production, mitochondrial membrane potential and protein, cell proliferation, apoptosis, and endothelial junction protein were detected to evaluate HGF effects. Moreover, we used the ALI mouse model to observe the mitochondria pathological changes with an electron microscope in vivo. Results: Our study demonstrated that HGF protected the endothelium via the suppression of ROS production and intracellular calcium uptake, which lead to increased mitochondrial membrane potential (JC-1 and mitochondria tracker green detection) and specific proteins (complex I), raised anti-apoptosis Messenger Ribonucleic Acid level (B-cell lymphoma 2 and Bcl-xL), and increased endothelial junction proteins (VE-cadherin and occludin). Reversely, mTOR inhibitor rapamycin and STAT3 inhibitor S3I-201 could raise oxidative stress and mitochondria-dependent apoptosis even with HGF treatment in LPS-induced endothelial cells. Similarly, mTORC1 as well as mTORC2 have the same protective effects in mitochondria damage and apoptosis. In in vivo experiments of ALI mouse, HGF also increased mitochondria structural integrity via the mTOR/STAT3 pathway. Conclusion: In all, these reveal that mTOR/STAT3 signaling mediates the HGF suppression effects to oxidative level, mitochondria-dependent apoptosis, and endothelial junction protein in ARDS, contributing to the pulmonary endothelial survival and barrier integrity.

HGF ameliorates cardiomyocyte apoptosis and inflammatory response in septic patients via the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway

HGF Alleviates Septic Endothelial Injury by Inhibiting Pyroptosis Via the Mtor Signalling Pathway.

Epigallocatechin-3-gallate Ameliorates LPS-induced Inflammation by Inhibiting the Phosphorylation of Akt and ERK Signaling Molecules in Rat H9c2 Cells

Hepatocyte Growth Factor-Induced Amelioration in Renal Interstitial Fibrosis is Associated with Reduced Expression of Alpha-Smooth Muscle Actin and Transforming Growth Factor-Beta1.

Role of hepatocyte growth factor on cardiomyocyte apoptosis and left ventricular remodeling after acute myocardial infarction

Hepatocyte growth factor protects pulmonary endothelial barrier against oxidative stress and mitochondria-dependent apoptosis

Effect of Hepatocyte Growth Factor on Myocardial Cell Apoptosis Induced by Tumor Necrosis Factor-Α and Actinomycin D

Inhibitory effect of hepatocyte growth factor on cardiomyocytes apoptosis is partly related to reduced calcium sensing receptor expression during a model of simulated ischemia/reperfusion

Cardiac-Specific Overexpression Of Insulin-Like Growth Factor I (Igf-1) Rescues Lipopolysaccharide-Induced Cardiac Dysfunction And Activation Of Stress Signaling In Murine Cardiomyocytes

Protective effects of hepatocyte growth promoting factor on multiple organ injuries of sepsis in rats

Adiponectin Attenuates Lipopolysaccharide-induced Apoptosis by Regulating the Cx43/PI3K/AKT Pathway

Peptide identification of hepatocyte growth-promoting factor and its function in cytoprotection and promotion of liver cell proliferation through the JAK2/STAT3/c-MYC pathway

Ad-HGF Improves the Cardiac Remodeling of Rat Following Myocardial Infarction by Upregulating Autophagy and Necroptosis and Inhibiting Apoptosis.

Effects of HGF in Celsior Solution on Levels of INF-γ. IL-4 and IL-10 in a Rat Liver Transplantation Model

Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions

Locally Overexpressing Hepatocyte Growth Factor Prevents Post-Ischemic Heart Failure by Inhibition of Apoptosis Via Calcineurin-Mediated Pathway and Angiogenesis.

Hepatocyte Growth Factor-Induced Amelioration in Chronic Renal Failure is Associated with Reduced Expression Ofα-Smooth Muscle Actin

Effects of up regulation of GDF-15 expression on biological characteristics and PI3K/AKT signaling pathway in H9C2 cardiomyocytes induced by H2O2

Fibroblast growth factor 5 overexpression ameliorated lipopolysaccharide-induced apoptosis of hepatocytes through regulation of the phosphoinositide-3-kinase/protein kinase B pathway

The Effect of HMGA1 in LPS-induced Myocardial Inflammation

Hepatocyte Growth Factor Intervention to Reduce Myocardial Injury and Improve Cardiac Function on Diabetic Myocardial Infarction Rats.